| Dr Alexandra Solosko, DO | |
|
511 E 3rd St, Suite 201, Bethlehem, PA 18015-2072 | |
| (484) 526-3060 | |
| (484) 526-4317 |
| Full Name | Dr Alexandra Solosko |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 511 E 3rd St, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205093622 | NPI | - | NPPES |
| Entity Name | Childrens Health Care Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598869059 PECOS PAC ID: 1355253527 Enrollment ID: O20040216001108 |
News Archive
Astellas Pharma Inc. confirmed today that it has entered into a confidentiality agreement with OSI Pharmaceuticals, Inc. Under the agreement, OSI will provide Astellas with access to certain non-public information. This follows Astellas' approach to OSI after OSI's announcement that its board of directors had instructed its management and financial advisors to contact interested third parties regarding a potential transaction.
Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that the U.S. Food and Drug Administration has cleared the company's Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.
A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse.
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
A Creighton University School of Medicine researcher has received a $3.3 million, five-year grant from the National Institutes of Health to study what role adult stem cells might play in repairing damaged coronary arteries, a complication that often occurs in patients after they undergo angioplasty and stenting.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexandra Solosko, DO 511 E 3rd St, Suite 201, Bethlehem, PA 18015-2072 Ph: (484) 526-3060 | Dr Alexandra Solosko, DO 511 E 3rd St, Suite 201, Bethlehem, PA 18015-2072 Ph: (484) 526-3060 |
News Archive
Astellas Pharma Inc. confirmed today that it has entered into a confidentiality agreement with OSI Pharmaceuticals, Inc. Under the agreement, OSI will provide Astellas with access to certain non-public information. This follows Astellas' approach to OSI after OSI's announcement that its board of directors had instructed its management and financial advisors to contact interested third parties regarding a potential transaction.
Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that the U.S. Food and Drug Administration has cleared the company's Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.
A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse.
Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.
A Creighton University School of Medicine researcher has received a $3.3 million, five-year grant from the National Institutes of Health to study what role adult stem cells might play in repairing damaged coronary arteries, a complication that often occurs in patients after they undergo angioplasty and stenting.
› Verified 4 days ago
Dr. Rafael I Colon-delgado, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2223 Linden St, Bethlehem, PA 18017 Phone: 610-866-2277 | |
David H Tauber, Pediatrics Medicare: Medicare Enrolled Practice Location: 801 Ostrum St # Pa, Bethlehem, PA 18015 Phone: 484-526-4000 | |
Dr. Hassan Bozorgnia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4315 Easton Ave, Suite 1, Bethlehem, PA 18020 Phone: 610-861-8830 Fax: 610-861-0891 | |
Afreen Subzposh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 240 Union Station Plz, Bethlehem, PA 18015 Phone: 610-654-3060 | |
Dr. Cynthia E. Weber, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 240 Union Station Plz, Bethlehem, PA 18015 Phone: 610-954-3060 | |
Laurel Alanna Erickson-parsons, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 240 Union Station, Bethlehem, PA 18015 Phone: 610-954-3060 Fax: 610-954-4317 |